MedTrace Logo

Relationship Between HIV-1 Subtype and ARV Response

NCT00585793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2015-10-01

No results posted yet for this study

Summary

Does subtype of HIV-1 affect the response of ARVs given to Ugandan children

Conditions

  • HIV Infections

Interventions

DRUG

NRTI/NNRTI/ Kaletra

Fixed dose and cild formulation Kaletra

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Frank M Graziano, MD/PhD · UWHC

Eligibility

Min Age
4 Months
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00585793 on ClinicalTrials.gov